Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:GBNH

Greenbrook TMS (GBNH) Stock Price, News & Analysis

Greenbrook TMS logo

About Greenbrook TMS Stock (NASDAQ:GBNH)

Key Stats

Today's Range
$0.04
$0.10
50-Day Range
$0.05
$0.38
52-Week Range
$0.10
$1.82
Volume
787,000 shs
Average Volume
3.60 million shs
Market Capitalization
$1.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services. As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.

Receive GBNH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Greenbrook TMS and its competitors with MarketBeat's FREE daily newsletter.

GBNH Stock News Headlines

Greenbrook TMS Strategic Acquisition and Restructuring by Neuronetics
Neuronetics Sees Q3 Revenue Rise Amid Strategic Acquisition
Download Our Tesla Ebook For Free
Like many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.
Neuronetics stockholders approve acquisition of Greenbrook TMS
Greenbrook TMS Shareholders Approve Neuronetics Acquisition
Neuronetics Agrees To Acquire Greenbrook In All-stock Transaction
GBNHF Greenbrook TMS Inc.
Greenbrook TMS Inc. Announces Delisting From Nasdaq
See More Headlines

GBNH Stock Analysis - Frequently Asked Questions

Greenbrook TMS Inc. (NASDAQ:GBNH) released its quarterly earnings results on Monday, August, 14th. The company reported ($0.30) earnings per share for the quarter, missing the consensus estimate of ($0.29) by $0.01. The company earned $18.35 million during the quarter, compared to the consensus estimate of $19.15 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Greenbrook TMS investors own include RENN Fund (RCG), Aceragen (ACGN), Alimera Sciences (ALIM), Alpine Summit Energy Partners (ALPS), Angion Biomedica (ANGN), AirNet Technology (ANTE) and Aptorum Group (APM).

Company Calendar

Last Earnings
8/14/2023
Today
11/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:GBNH
Fax
N/A
Employees
492
Year Founded
N/A

Profitability

Net Income
$-61,730,000.00
Pretax Margin
-83.55%

Debt

Sales & Book Value

Annual Sales
$69.10 million
Book Value
($1.72) per share

Miscellaneous

Free Float
31,959,000
Market Cap
$1.96 million
Optionable
Not Optionable
Beta
2.19
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.

Get This Free Report

This page (NASDAQ:GBNH) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners